These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 30323574)

  • 21. Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis.
    Upala S; Jaruvongvanich V; Wijarnpreecha K; Sanguankeo A
    J Bone Miner Metab; 2017 Nov; 35(6):685-693. PubMed ID: 27928661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?
    Targher G; Lonardo A; Rossini M
    J Endocrinol Invest; 2015 Aug; 38(8):817-25. PubMed ID: 26003827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
    Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease.
    Azzu V; Vacca M; Virtue S; Allison M; Vidal-Puig A
    Gastroenterology; 2020 May; 158(7):1899-1912. PubMed ID: 32061598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
    Adams LA; Anstee QM; Tilg H; Targher G
    Gut; 2017 Jun; 66(6):1138-1153. PubMed ID: 28314735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011.
    Ahn SH; Seo DH; Kim SH; Nam MS; Hong S
    Osteoporos Int; 2018 Jan; 29(1):181-190. PubMed ID: 29051986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease.
    Wang X; Rao H; Liu F; Wei L; Li H; Wu C
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease.
    Parker R; Weston CJ; Miao Z; Corbett C; Armstrong MJ; Ertl L; Ebsworth K; Walters MJ; Baumart T; Newland D; McMahon J; Zhang P; Singh R; Campbell J; Newsome PN; Charo I; Schall TJ; Adams DH
    Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G483-G493. PubMed ID: 29420066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults.
    Lee SH; Yun JM; Kim SH; Seo YG; Min H; Chung E; Bae YS; Ryou IS; Cho B
    J Endocrinol Invest; 2016 Nov; 39(11):1329-1336. PubMed ID: 27561910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults.
    Wei Y; Liu J; Wang G; Wang Y
    Biol Sex Differ; 2023 Oct; 14(1):69. PubMed ID: 37814297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block.
    Musso G
    Endocrine; 2012 Oct; 42(2):237-9. PubMed ID: 22801991
    [No Abstract]   [Full Text] [Related]  

  • 34. Iron and non-alcoholic fatty liver disease.
    Britton LJ; Subramaniam VN; Crawford DH
    World J Gastroenterol; 2016 Sep; 22(36):8112-22. PubMed ID: 27688653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
    Kalavalapalli S; Leiva EG; Lomonaco R; Chi X; Shrestha S; Dillard R; Budd J; Romero JP; Li C; Bril F; Samraj G; Pennington J; Townsend P; Orlando F; Shetty S; Mansour L; Silva-Sombra LR; Bedossa P; Malaty J; Barb D; Gurka MJ; Cusi K
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1192-1201. PubMed ID: 36378995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.
    Stojsavljević S; Gomerčić Palčić M; Virović Jukić L; Smirčić Duvnjak L; Duvnjak M
    World J Gastroenterol; 2014 Dec; 20(48):18070-91. PubMed ID: 25561778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome.
    Lim S; Taskinen MR; Borén J
    Obes Rev; 2019 Apr; 20(4):599-611. PubMed ID: 30589487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Manne V; Handa P; Kowdley KV
    Clin Liver Dis; 2018 Feb; 22(1):23-37. PubMed ID: 29128059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.
    Saponaro C; Gaggini M; Gastaldelli A
    Curr Diab Rep; 2015 Jun; 15(6):607. PubMed ID: 25894944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.